Ang Likang: The cumulative number of pledged shares of Shengzhou Juntai Investment Co., Ltd. is 16.77 million shares_ Oriental Fortune Net Post date May 20, 2022 — 17:46 Post Lock Read More Ang Likang (002940.SZ): Controlling Shareholder Pledges 3.5 Million Shares_Stock Information_Market Gold Online Post date May 20, 2022 — 17:45 Post Lock Read More Ang Likang (002940): Pledge of part of the shares of the company's controlling shareholder- CFi.CN Zhongcai Network Post date May 20, 2022 — 17:40 Post Lock Read More Hengrui Medicine (600276): Hengrui Medicine's progress on drug clinical trials CFi.CN Zhongcai Network Post date May 12, 2022 — 23:01 Post Lock Read More Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com Post date May 12, 2022 — 07:15 Post Lock Read More The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang (002940.SZ): Controlling Shareholder Pledges 3.5 Million Shares_Stock Information_Market Gold Online Post date May 20, 2022 — 17:45 Post Lock Read More Ang Likang (002940): Pledge of part of the shares of the company's controlling shareholder- CFi.CN Zhongcai Network Post date May 20, 2022 — 17:40 Post Lock Read More Hengrui Medicine (600276): Hengrui Medicine's progress on drug clinical trials CFi.CN Zhongcai Network Post date May 12, 2022 — 23:01 Post Lock Read More Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com Post date May 12, 2022 — 07:15 Post Lock Read More The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang (002940): Pledge of part of the shares of the company's controlling shareholder- CFi.CN Zhongcai Network Post date May 20, 2022 — 17:40 Post Lock Read More Hengrui Medicine (600276): Hengrui Medicine's progress on drug clinical trials CFi.CN Zhongcai Network Post date May 12, 2022 — 23:01 Post Lock Read More Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com Post date May 12, 2022 — 07:15 Post Lock Read More The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Hengrui Medicine (600276): Hengrui Medicine's progress on drug clinical trials CFi.CN Zhongcai Network Post date May 12, 2022 — 23:01 Post Lock Read More Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com Post date May 12, 2022 — 07:15 Post Lock Read More The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com Post date May 12, 2022 — 07:15 Post Lock Read More The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest private equity fund news: A-shares are the most uncomfortable, tens of billions of private equity Gao Yi Assets, Ningquan Assets Yang Dong are actively bottom-hunting, some people "earn treasures" and some "buy thunder" Yahui.com Post date May 11, 2022 — 22:15 Post Lock Read More Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Anglikang intends to transfer the relevant technical achievements of Central South University with Kerui Bio and form a joint venture company Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture_ Securities Times Network Post date May 11, 2022 — 20:50 Post Lock Read More Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang: Signing a Technology Transfer Contract and Forming a Joint Venture Post date May 11, 2022 — 20:43 Post Lock Read More Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang (002940.SZ): intends to jointly acquire the technical achievements of "new drug delivery system and preparation method" with Kerui Bio and form a joint venture Post date May 11, 2022 — 20:40 Post Lock Read More Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang (002940): Independent directors' pre-approval opinions on matters related to the seventeenth meeting of the third board of directors- CFi.CN Zhongcai Network Post date May 11, 2022 — 20:35 Post Lock Read More A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A-share bottom grinding is the most uncomfortable, tens of billions of private equity Gaoyi Assets, Ningquan Assets Yang Dong actively hunt for bottoms, some people "find treasures" and some people "buy thunder" Post date May 11, 2022 — 11:05 Post Lock Read More Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Only 708 yuan in revenue in the first quarter? ! This listed company is on fire! 25 days after listing, it fell 55%, and the background was exposed – yqqlm Post date April 29, 2022 — 02:14 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang: The performance of the acquisition target is unclear – yqqlm Post date April 27, 2022 — 17:35 Post Lock Read More Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Ang Likang: The performance of the acquisition target is unclear_Oriental Fortune Net Post date April 27, 2022 — 17:30 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 19, 2022 — 19:09 Post Lock Read More 4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews Post date April 19, 2022 — 18:12 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Post date April 19, 2022 — 09:35 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua Post date April 19, 2022 — 09:30 Post Lock Read More The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina Post date April 19, 2022 — 07:36 Post Lock Read More
Caishen.CoCaishen.Co